← Back to home
Comparison · Analytics

cfr vs pharmaverseadam

A side-by-side editorial comparison of cfr and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.

cfr vs pharmaverseadam: at a glance

Featurecfrpharmaverseadam
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesepidemiology, severity-estimation, outbreak-analytics, epiversepharmaverse, clinical-data, adam, test-data
Last editorial update5h ago1h ago
WebsiteVisit →Visit →

What is cfr?

cfr packaged delay-corrected severity estimation, then went quiet on maintenance.

The package estimates disease severity and case ascertainment while correcting for the delay between a case being reported and its outcome being known. After the 0.1.1 rework of the estimation internals and a maintainer handover to Adam Kucharski, activity dropped to a vignette and an R-devel compatibility patch in February 2025.

Read the full cfr trajectory →

What is pharmaverseadam?

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

Read the full pharmaverseadam trajectory →

cfr vs pharmaverseadam: editorial side-by-side

C
cfr
ANALYTICS
0.0

cfr packaged delay-corrected severity estimation, then went quiet on maintenance.

◆ Current state

The package estimates disease severity and case ascertainment while correcting for the delay between a case being reported and its outcome being known. After the 0.1.1 rework of the estimation internals and a maintainer handover to Adam Kucharski, activity dropped to a vignette and an R-devel compatibility patch in February 2025.

◆ Where it's heading

The methodological work is done and consolidated: likelihood approximation is now selected automatically from outbreak size and an initial severity estimate, and the internals were renamed with a dot prefix to close the public surface down to cfr_static(), cfr_rolling() and the data-preparation generic. Releases since have been documentation and compatibility only.

◆ Prediction

The 0.1.0 notes flagged time-varying ascertainment as future work and it has not appeared in the two releases since; nothing in these entries indicates when or whether it lands.

P0.0

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

◆ Current state

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

◆ Where it's heading

Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.

◆ Prediction

Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.

Alternatives to cfr and pharmaverseadam

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either cfr or pharmaverseadam.

See all cfr alternatives → · See all pharmaverseadam alternatives →

Recent activity from cfr and pharmaverseadam

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
  2. 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
  3. 1y agocfrR-devel difftime patch and an individual-data vignette
  4. 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
  5. 2y agopharmaverseadam1.0 declares the dataset collection stable
  6. 2y agocfrSeverity estimator picks its own likelihood approximation
  7. 2y agocfrDelay-corrected severity and ascertainment estimation on CRAN
  8. 2y agopharmaverseadamFirst release of the ADaM dataset collection

Frequently asked questions

What is the difference between cfr and pharmaverseadam?

They serve adjacent needs but don't currently overlap on shipped themes. cfr and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is cfr better than pharmaverseadam?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. cfr and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to cfr?

Top cfr alternatives in Analytics are ranked by recent ship velocity. Browse the "cfr alternatives" section above for the current picks, or visit /alternatives/cfr for the full list with editorial commentary on each.

What are the best alternatives to pharmaverseadam?

Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.